Nautilus Biotechnology, Inc. (NAUT) Current Ratio
- Current ratio · latest quarter: Value 10.14×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 10.14× | Current assets / current liabilities. $87.63M ÷ $8.64M ≈ 10.14× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 87.63M USD | Assets, Current |
| Current obligations | 8.64M USD | Liabilities, Current |
| Cash and equivalents | 13.17M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 70.86M USD | Debt Securities, Available-for-sale, Current |
| Customer receivables | (m) | |
| Inventory | 600.00K USD | Inventory, Net |
| Payables | 1.09M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $87.63M | $8.64M | $13.17M | $70.86M | (m) | $600.00K | $1.09M | (m) | 10.14× |
| 2026-03-31 | $98.83M | $8.34M | $14.63M | $81.24M | (m) | $300.00K | $1.19M | (m) | 11.85× |
| 2025-12-31 | $105.96M | $7.95M | $12.39M | $91.02M | (m) | (m) | $943.00K | (m) | 13.33× |
| 2025-09-30 | $134.32M | $8.98M | $23.88M | $107.55M | (m) | (m) | $893.00K | (m) | 14.95× |
| 2025-06-30 | $150.72M | $8.14M | $34.46M | $113.42M | (m) | (m) | $974.00K | (m) | 18.52× |
| 2025-03-31 | $141.60M | $8.16M | $33.24M | $105.57M | (m) | (m) | $841.00K | (m) | 17.36× |
| 2024-12-31 | $132.83M | $7.63M | $27.65M | $102.25M | (m) | (m) | $987.00K | (m) | 17.40× |
| 2024-09-30 | $144.21M | $8.66M | $4.41M | $136.20M | (m) | (m) | $1.49M | (m) | 16.65× |
| 2024-06-30 | $170.93M | $8.68M | $24.89M | $142.56M | (m) | (m) | $1.63M | (m) | 19.69× |
| 2024-03-31 | $185.09M | $9.21M | $25.73M | $155.64M | (m) | (m) | $1.86M | (m) | 20.09× |
| 2023-12-31 | $176.84M | $9.12M | $19.40M | $154.02M | (m) | (m) | $1.64M | (m) | 19.39× |
| 2023-09-30 | $186.79M | $8.89M | $74.10M | $109.19M | (m) | (m) | $1.14M | (m) | 21.00× |
| 2023-06-30 | $166.70M | $7.89M | $72.14M | $91.16M | (m) | (m) | $1.22M | (m) | 21.13× |
| 2023-03-31 | $170.48M | $7.93M | $88.50M | $78.84M | (m) | (m) | $1.27M | (m) | 21.50× |
| 2022-12-31 | $187.21M | $6.79M | $114.52M | $69.95M | (m) | (m) | $1.27M | (m) | 27.57× |
| 2022-09-30 | $261.22M | $6.43M | $188.93M | $69.04M | (m) | (m) | $823.00K | (m) | 40.60× |
| 2022-06-30 | $303.45M | $6.10M | $210.35M | $88.98M | (m) | (m) | $1.43M | (m) | 49.75× |
| 2022-03-31 | $327.06M | $6.41M | $188.62M | $135.50M | (m) | (m) | $1.49M | (m) | 51.06× |
| 2021-12-31 | $349.22M | $5.81M | $185.62M | $160.11M | (m) | (m) | $1.72M | (m) | 60.09× |
| 2021-09-30 | $352.22M | $4.21M | $190.24M | $157.10M | (m) | (m) | $1.50M | (m) | 83.68× |
| 2021-06-30 | $374.63M | $3.23M | $288.39M | $84.76M | (m) | (m) | $1.23M | (m) | 115.95× |
| 2021-03-31 | $935.64K | $1.80M | (m) | (m) | (m) | (m) | $116.83K | (m) | 0.52× |
| 2020-12-31 | $77.66M | $3.02M | $36.61M | $40.13M | (m) | (m) | $470.00K | (m) | 25.73× |
| 2020-09-30 | $1.43M | $128.66K | (m) | (m) | (m) | (m) | $6.09K | (m) | 11.15× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |